04.29.25 -- STREAM Edition: How The FDA Strengthens Industry Collaboration

In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich discuss the ways in which couriers might optimize their workflow.

Learn about a system that uses a gentle elutriation process to give manufacturers a cleaner cell population to begin cell therapy production processes such as CAR-T.

High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.

Learn how a collaborative partnership streamlined antibody-drug conjugate processes using a single-use, multi-step system to reduce operator time by 68%.

Discover a device that precisely controls glucose and lactate in cell culture and fermentation to reduce manual labor, contamination risks, and cell stress while offering remote data viewing.

Kimberly Benton, Ph.D., of Dark Horse Consulting, and Bambi Grilley, RPh, of Baylor College of Medicine and ISCT, discuss the FDA's growing commitment to regulatory support for cell and gene therapies.

Viral vector-based gene therapies offer hope for treating rare genetic disorders and complex conditions. Discover an advanced AAV producer cell line that is revolutionizing accessible gene therapy production.

Explore AAV shedding assessment using qPCR, featuring experts discussing assay development, monitoring challenges, and ensuring safety in clinical studies.

Watch as experts explore key innovations in plasmid design and production, highlighting how these advancements can directly enhance biomanufacturing workflows.

Discover an innovative TCT-LS process for CAR-T cell therapy that targets blood cancers, solid tumors, and infectious diseases, as well as learn about its unique features, limitations, and how it enhances strategies.